收藏切换
Research progress in the manufacturing process of Streptococcus pneumoniae capsular polysaccharide from the perspective of vaccine safety
收藏切换
PDF
Yuelong LI1, 2, Jianlong WANG1, Jiankai LIU1, 2, Haifa ZHENG1, 2, *
Acta Microbiologica Sinica | 2024, 64(10) : 3656 - 3669
Less
收藏切换
Acta Microbiologica Sinica | 2024, 64(10): 3656-3669
Reviews
Research progress in the manufacturing process of Streptococcus pneumoniae capsular polysaccharide from the perspective of vaccine safety
Full
Yuelong LI1, 2, Jianlong WANG1, Jiankai LIU1, 2, Haifa ZHENG1, 2, *
Affiliations
  • 1 Beijing Minhai Biotechnology Co., Ltd., Beijing 102600, China
  • 2 Beijing Key Laboratory of New Technology Research of Conjugate Vaccine, Beijing 102600, China
Published: 2024-07-16 doi: 10.13343/j.cnki.wsxb.20240253
Outline
收藏切换

The pneumococcal vaccines play an indispensable role in defending against various invasive and non-invasive diseases caused by Streptococcus pneumoniae. The capsular polysaccharide is a key antigen, while the impurity residues in the capsular polysaccharide cause side effects of pneumococcal polysaccharide vaccines and conjugate vaccines. As the global demand for high-valent pneumococcal vaccines covering a wide range of serotypes keeps increasing, it is urgent and crucial to develop efficient and scalable production technologies for high-purity capsular polysaccharide antigens. The safety and quality attributes of capsular polysaccharide are influenced by multiple factors encompassing the selection of pathogen strains, formulation of culture media, control of fermentation processes, and purification technologies. Following the concept of Quality by Design (QbD) and the process development path, this article systematically summarizes the knowledge and experience throughout the entire process ranging from upstream strain screening and optimization, refined fermentation process design, to downstream purification, aiming to provide comprehensive and in-depth theoretical guidance and practical strategies for building and improving the production system of capsular polysaccharide.

pneumococcal vaccine  /  capsular polysaccharide  /  antigen  /  quality  /  impurities
Yuelong LI, Jianlong WANG, Jiankai LIU, Haifa ZHENG. Research progress in the manufacturing process of Streptococcus pneumoniae capsular polysaccharide from the perspective of vaccine safety[J]. Acta Microbiologica Sinica, 2024 , 64 (10) : 3656 -3669 . DOI: 10.13343/j.cnki.wsxb.20240253
  • Beijing Postdoctoral Research Foundation(2023-ZZ-32)
Year 2024 volume 64 Issue 10
PDF
134
59
Cite this Article
BibTeX
Article Info
doi: 10.13343/j.cnki.wsxb.20240253
  • Receive Date:2024-04-23
  • Online Date:2026-03-21
  • Published:2024-07-16
Article Data
Affiliations
History
  • Received:2024-04-23
  • Accepted:2024-07-03
Funding
Beijing Postdoctoral Research Foundation(2023-ZZ-32)
Affiliations
    1 Beijing Minhai Biotechnology Co., Ltd., Beijing 102600, China
    2 Beijing Key Laboratory of New Technology Research of Conjugate Vaccine, Beijing 102600, China

Corresponding:

*ZHENG Haifa, E-mail:
References
Share
https://castjournals.cast.org.cn/joweb/wswxb/EN/10.13343/j.cnki.wsxb.20240253
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT